These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease. Diller GP; Dimopoulos K; Kaya MG; Harries C; Uebing A; Li W; Koltsida E; Gibbs JS; Gatzoulis MA Heart; 2007 Aug; 93(8):974-6. PubMed ID: 17639112 [TBL] [Abstract][Full Text] [Related]
5. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007 [TBL] [Abstract][Full Text] [Related]
6. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease. Durongpisitkul K; Jakrapanichakul D; Sompradikul S J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984 [TBL] [Abstract][Full Text] [Related]
7. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease. Baptista R; Castro G; da Silva AM; Monteiro P; Providência LA Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920 [TBL] [Abstract][Full Text] [Related]
8. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease. Ibrahim R; Granton JT; Mehta S Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459 [TBL] [Abstract][Full Text] [Related]
9. [Outcome of oral bosentan in children with congenital heart disease associated pulmonary arterial hypertension]. Xu ZM; Zhu LM; Cai XM; Ji G; Liu JF; Su ZK Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2106-9. PubMed ID: 20058613 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease. Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951 [TBL] [Abstract][Full Text] [Related]
11. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. Schuuring MJ; Bouma BJ; Cordina R; Gatzoulis MA; Budts W; Mullen MP; Vis JC; Celermajer D; Mulder BJ Int J Cardiol; 2013 Mar; 164(1):106-10. PubMed ID: 21763017 [TBL] [Abstract][Full Text] [Related]
12. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease. Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050 [TBL] [Abstract][Full Text] [Related]
13. Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. McLaughlin V; Channick RN; Ghofrani HA; Lemarié JC; Naeije R; Packer M; Souza R; Tapson VF; Tolson J; Al Hiti H; Meyer G; Hoeper MM Eur Respir J; 2015 Aug; 46(2):405-13. PubMed ID: 26113687 [TBL] [Abstract][Full Text] [Related]
14. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008 [TBL] [Abstract][Full Text] [Related]
16. Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children. Gilbert N; Luther YC; Miera O; Nagdyman N; Ewert P; Berger F; Lange PE; Schulze-Neick I Z Kardiol; 2005 Sep; 94(9):570-4. PubMed ID: 16142516 [TBL] [Abstract][Full Text] [Related]
17. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483 [No Abstract] [Full Text] [Related]
18. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study on sildenafil in treatment of pregnant women with pulmonary arterial hypertension]. Sun X; Wang K; Wang W; Li B Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):414-8. PubMed ID: 25169631 [TBL] [Abstract][Full Text] [Related]